Blackston Financial Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $964K | Buy |
5,193
+274
| +6% | +$50.9K | 0.44% | 39 |
|
|
2025
Q1 | $1.03M | Buy |
4,919
+91
| +2% | +$19.1K | 0.52% | 32 |
|
|
2024
Q4 | $858K | Buy |
4,828
+117
| +2% | +$20.8K | 0.43% | 37 |
|
|
2024
Q3 | $931K | Buy |
4,711
+436
| +10% | +$86.1K | 0.48% | 29 |
|
|
2024
Q2 | $733K | Buy |
4,275
+3,138
| +276% | +$538K | 0.41% | 28 |
|
|
2024
Q1 | $207K | Sell |
1,137
-2,335
| -67% | -$425K | 0.14% | 60 |
|
|
2023
Q4 | $538K | Buy |
3,472
+43
| +1% | +$6.66K | 0.34% | 42 |
|
|
2023
Q3 | $511K | Buy |
3,429
+219
| +7% | +$32.6K | 0.36% | 43 |
|
|
2023
Q2 | $432K | Sell |
3,210
-339
| -10% | -$45.6K | 0.31% | 49 |
|
|
2023
Q1 | $566K | Sell |
3,549
-164
| -4% | -$26.2K | 0.42% | 39 |
|
|
2022
Q4 | $600K | Sell |
3,713
-88
| -2% | -$14.2K | 0.44% | 38 |
|
|
2022
Q3 | $557K | Buy |
3,801
+287
| +8% | +$42.1K | 0.39% | 43 |
|
|
2022
Q2 | $534K | Buy |
3,514
+994
| +39% | +$151K | 0.35% | 39 |
|
|
2022
Q1 | $272K | Sell |
2,520
-379
| -13% | -$40.9K | 0.18% | 65 |
|
|
2021
Q4 | $393K | Buy |
+2,899
| New | +$393K | 0.23% | 51 |
|